Metabolomics insights into Charcot–Marie–Tooth disease: toward biomarker discovery
Our study data provide information about plasma metabolite levels in CMT patients. However, these findings suggest that the metabolites mentioned above might be unspecific biomarkers of neuropathy and do not reflect disease severity.
Authors
- Kristaps Klavins (ORCID: https://orcid.org/0000-0001-9577-9990)
- Dmitrijs Rots (ORCID: https://orcid.org/0000-0002-4890-9147)
- Signe Šetlere (ORCID: https://orcid.org/0000-0003-1983-6169)
- Linda Gailīte (ORCID: https://orcid.org/0000-0002-7219-1294)
- Viktorija Ķēniņa (ORCID: https://orcid.org/0000-0002-7468-1908)
- Theresa Schiemer (ORCID: https://orcid.org/0009-0000-6508-0636)
- Annija Vaska (ORCID: https://orcid.org/0000-0002-8724-6630)
Institutions
- Riga Technical University (LV)
- Children's Clinical University Hospital (LV)
- Riga Stradiņš University (LV)
Publication Details
- Journal
- Frontiers in Neurology
- Published
- 2025-05-19
- DOI
- https://doi.org/10.3389/fneur.2025.1543547
- Citations
- 2
- Primary Topic
- Hereditary Neurological Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.82